California and Leqvio FTOs

Quote



anonymous said:
what happened? How could they get in trouble? Every rep I know gave clinical indication and explained how FTO worked as trained by novartis. If the office faxed it in for wrong patient type on their own how would it be those reps fault? Doesn’t make any sense specifically because of HIPPA- u can’t see or know patient info
Click to expand...
Well it starts when leadership says you can make or double goal on Leqvio with FTO'S. And maybe it inspires some HCP'S to actually ID and research benefits on appropriate pats. But as November rolls into December RD/ABL/Reps get worried and start suggesting ordering for everyone and sort it out by Shot #2. And if you happen to make $10-30K more in bonus what's the harm.
Our District was short a handful of shots to "double" bonus bc we had DOZENS held up by All Care. Amazing how Novartis didn't have to pay out all that bonus, dumped short dated "samples" and told investors we rocked the launch.
SEC & FDA should be looking hard at Duane but I'm sure he's already headed to another opportunity for glory somewhere else.
 


anonymous said:
Well it starts when leadership says you can make or double goal on Leqvio with FTO'S. And maybe it inspires some HCP'S to actually ID and research benefits on appropriate pats. But as November rolls into December RD/ABL/Reps get worried and start suggesting ordering for everyone and sort it out by Shot #2. And if you happen to make $10-30K more in bonus what's the harm.
Our District was short a handful of shots to "double" bonus bc we had DOZENS held up by All Care. Amazing how Novartis didn't have to pay out all that bonus, dumped short dated "samples" and told investors we rocked the launch.
SEC & FDA should be looking hard at Duane but I'm sure he's already headed to another opportunity for glory somewhere else.
Click to expand...

Duane would do well to be gone before the class-action lawsuit hits. There's no reason for those reps and managers to go quietly, nor should they.
 


anonymous said:
Well it starts when leadership says you can make or double goal on Leqvio with FTO'S. And maybe it inspires some HCP'S to actually ID and research benefits on appropriate pats. But as November rolls into December RD/ABL/Reps get worried and start suggesting ordering for everyone and sort it out by Shot #2. And if you happen to make $10-30K more in bonus what's the harm.
Our District was short a handful of shots to "double" bonus bc we had DOZENS held up by All Care. Amazing how Novartis didn't have to pay out all that bonus, dumped short dated "samples" and told investors we rocked the launch.
SEC & FDA should be looking hard at Duane but I'm sure he's already headed to another opportunity for glory somewhere else.
Click to expand...
SEC for sure. NVS claimed they made all these sales but they were all a sham. Investigation is necessary and all leaders held accountable.
 






The whole FTO scheme was a hyped up scam for Wall Street. I'm in Calif., and heard nothing but promote the FTO's - there's no limit. Physician enticement to use Leqvio via FTO should be investigated and all managers involved held accountable!!!
 


























Hey DOJ, Novartis Legal, Novartis compliance…please investigate MO in Texas and put us all out of our misery. She is out of control and the reason this company will get into more trouble with the government
 



Write your reply...
Top Bottom
Back
Quote